Feasibility of Placing Bravo PH Capsule in Proximal Esophagus

Completed · Not applicable · Has a placebo group

Conditions studied: Gastroesophageal Reflux Disease

In brief

Assessing the feasibility and patient tolerance to placement of Bravo PH capsule in proximal esophagus. There will be no difference in patient-perception of a proximally-placed Bravo esophageal pH monitor compared with a distal monitor.

Key facts

Study ID

NCT00378898

Run by

Vanderbilt University Medical Center

People needed

39

Starts

2006-09-01

Expected to finish

2009-07-01

Last updated by the study team

2017-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Inclusion criteria will include the following:
• Patients greater than or equal to 18 years of age
• Patients having regularly scheduled upper endoscopy with planned Bravo pH monitor testing
• Patients with known GERD based on symptoms (heartburn, regurgitation) and response to a proton pump inhibitor or esophagitis on EGD as well as those with extraesophageal GERD (cough, asthma and throat discomfort).

You may not qualify if…

• Exclusion criteria will include the following:
• Previous surgical procedures to the upper esophagus
• History of bleeding diathesis or coagulopathy
• Stroke or transient ischemic attack within the past 6 months
• GI bleeding within the previous 6 months
• Known esophageal varices
• Significant medical illness (i.e., congestive heart failure)
• Pregnancy

Where it is running

• The Vanderbilt Clinic/ Endoscopy Lab — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.